These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9723233)

  • 1. Pharmacokinetic studies of oral and intravenous cyclosporine in prekidney transplant patient.
    Wacke R; Bast R; Rohde B; Prall F; Seiter H; Drewelow B
    Transplant Proc; 1998 Aug; 30(5):1663. PubMed ID: 9723233
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation.
    Gusmano R; Basile GC; Perfumo F; Ginevri F; Verrina E; Famularo L; Corbetta G
    Transplant Proc; 1998 Aug; 30(5):1985-7. PubMed ID: 9723362
    [No Abstract]   [Full Text] [Related]  

  • 3. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period.
    Amante AJ; Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2162-3. PubMed ID: 8769187
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A; Pinto VM; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion from standard cyclosporine to Neoral in lung transplant recipients.
    Kesten S; Scavuzzo M; Laurin L; Tan A; Chaparro C
    Transplant Proc; 1998 Aug; 30(5):1895-7. PubMed ID: 9723324
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients.
    Klauser R; Irschik H; Kletzmayr J; Sturm I; Brunner W; Woloszczuk W; Kovarik J
    Transplant Proc; 1995 Dec; 27(6):3427-9. PubMed ID: 8540034
    [No Abstract]   [Full Text] [Related]  

  • 7. Abbreviating area under the curves further: a practical approach to monitoring extended pharmacokinetics with Neoral.
    Sindhi R; Shah J; Foley L; Bucsis J; Kyryliuk T; Baliga PK; Rajagopalan PR
    Transplant Proc; 1998 Jun; 30(4):1197-8. PubMed ID: 9636485
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantation. Canadian Liver Transplant Study Group.
    Transplant Proc; 1998 Aug; 30(5):1826-7. PubMed ID: 9723297
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G
    Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 12. Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
    Kelles A; Herman J; Tjandra-Maga TB; Van Damme-Lombaerts R
    Transplant Proc; 1998 Aug; 30(5):1995-6. PubMed ID: 9723366
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Toze CL; Corr T; Currie C; Strong DK; Keown PA
    Transplant Proc; 1998 Aug; 30(5):1668-70. PubMed ID: 9723236
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimization of cyclosporine therapy in kidney transplantation.
    Remuzzi G; Perico N; Gaspari F
    Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
    Cooney GF; Jeevanandam V; Choudhury S; Feutren G; Mueller EA; Eisen HJ
    Transplant Proc; 1998 Aug; 30(5):1892-4. PubMed ID: 9723323
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of mean relative bioavailability of cyclosporine Sandimmune and Neoral using NONMEM in renal transplant recipients.
    Lee KL; Lee KT; Chung HM; Lin YP
    Transplant Proc; 1998 Nov; 30(7):3526-9. PubMed ID: 9838545
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with new cyclosporine formulations: Consupren and Neoral in renal transplant patients.
    Barbari A; Stephan A; Kamel G; Kilany H; Masri MA
    Transplant Proc; 1997 Nov; 29(7):2941-4. PubMed ID: 9365622
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
    Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
    Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR; Weiskittel P; Shah M; Peddi VR; Canafax D; Schroeder TJ
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.